- Acumen Powered by Robins Kaplan LLP®
- Affirmative Recovery
- American Indian Law and Policy
- Antitrust and Trade Regulation
- Appellate Advocacy and Guidance
- Business Litigation
- Civil Rights and Police Misconduct
- Class Action Litigation
- Commercial/Project Finance and Real Estate
- Corporate Governance and Special Situations
- Corporate Restructuring and Bankruptcy
- Domestic and International Arbitration
- Entertainment and Media Litigation
- Health Care Litigation
- Insurance and Catastrophic Loss
- Intellectual Property and Technology Litigation
- Mass Tort Attorneys
- Medical Malpractice Attorneys
- Personal Injury Attorneys
- Telecommunications Litigation and Arbitration
- Wealth Planning, Administration, and Fiduciary Disputes
Acumen Powered by Robins Kaplan LLP®
Ediscovery, Applied Science and Economics, and Litigation Support Solutions
-
October 14, 2024Raoul Shah Recognized as New Volunteer Attorney of the Year by Tubman
-
October 14, 2024Robins Kaplan Receives LAAC Award of Merit for Landmark Ruling Benefiting Homeless Veterans
-
October 10, 2024Michael Collyard and Ronald Schutz Named to Minnesota Lawyer’s Power 30: Business Litigation List
-
October 20, 2024License Agreement Disputes:
-
October 21, 2024How Much Did We Invest in AI?
-
October 22, 2024Justice for All: Minnesota's Civil Legal Aid and Pro Bono Landscape
-
September 2024Meet Our New Partner and Trial Advocacy Seminar Keynote Speaker: B. Todd Jones
-
September 2024Q&A with Alan Harter, Founder of Pactolus Private Wealth Management
-
August 2024Recruiting & Retaining Diverse Attorneys: Building an Inclusive Legal Profession
-
September 16, 2022Uber Company Systems Compromised by Widespread Cyber Hack
-
September 15, 2022US Averts Rail Workers Strike With Last-Minute Tentative Deal
-
September 14, 2022Hotter-Than-Expected August Inflation Prompts Massive Wall Street Selloff
Find additional firm contact information for press inquiries.
Find resources to help navigate legal and business complexities.
Read our attorneys' take on the latest news and trends in the legal and business industries.
ANDA Approvals
Spring 2017
| Approval Date | Reference Listed Drug | Generic Drug Name | NDA Holder | ANDA Applicant |
|---|---|---|---|---|
| 1/3/2017 | Mirapex ER | Pramipexole Dihydrochloride | Boehringer Ingelheim | Actavis |
| 1/3/2017 | Robinul / Robinul Forte | Glycopyrrolate | Casper Pharma | Appco Pharma |
| 1/4/2017 | Maxipime | Cefepime Hydrochloride | Hospira | Sagent Pharms |
| 1/4/2017 | Levetiracetam in Sodium Chloride | Levetiracetam in Sodium Chloride | HQ Speciality Pharma | Aurobindo Pharma |
| 1/5/2017 | Proscar | Finasteride | Merck | Alkem Labs |
| 1/6/2017 | Propecia | Finasteride | Merck | Alkem Labs |
| 1/6/2017 | Cymbalta | Duloxetine Hydrochloride | Eli Lilly | Ajanta Pharma |
| 1/9/2017 | Abilify | Aripiprazole | Otsuka | Stason Pharms |
| 1/9/2017 | Lipitor | Atorvastatin Calcium | Pfizer | Invagen Pharms |
| 1/10/2017 | Patanol | Olopatadine Hydrochloride | Novartis | Akorn |
| 1/10/2017 | Choline C-11 | Choline C-11 | MCPRF | WA Univ Sch Med |
| 1/11/2017 | Maxalt-MLT | Rizatriptan Benzoate | Merck | Panacea Biotec |
| 1/13/2017 | Methotrexate Sodium | Methotrexate Sodium | Dava Pharms | Zydus Pharms USA |
| 1/13/2017 | Zosyn | Piperacillin / Tazobactam | Wyeth | Apollo Pharms |
| 1/13/2017 | Zosyn | Piperacillin / Tazobactam | Wyeth | Apollo Pharms |
| 1/17/2017 | Xyrem | Sodium Oxybate | Jazz Pharms | West-Ward Pharms |
| 1/18/2017 | Aggrenox | Aspirin / Dipyridamole | Boehringer Ingelheim | Sandoz |
| 1/18/2017 | Aggrenox | Aspirin / Dipyridamole | Boehringer Ingelheim | Impax Labs |
| 1/18/2017 | Aggrenox | Aspirin / Dipyridamole | Boehringer Ingelheim | Par Pharm |
| 1/19/2017 | Robaxin | Methocarbamol | West-Ward Pharms | Renaissance Pharma |
| 1/20/2017 | Paxil CR | Paroxetine Hydrochloride | Apotex | Lupin |
| 1/20/2017 | Flomax | Tamsulosin Hydrochloride | Boehringer Ingelheim | Macleods Pharms |
| 1/20/2017 | Taxotere | Docetaxel | Sanofi Aventis / Accord Healthcare | DFB Oncology |
| 1/20/2017 | Topicort | Desoximetasone | Taro | Perrigo |
| 1/23/2017 | Aleve ( OTC) | Naproxen Sodium (OTC) | Bayer | LNK Intl |
| 1/23/2017 | Mirapex ER | Pramipexole Dihydrochloride | Boehringer Ingelheim | MacLeods Pharms |
| 1/23/2017 | Ampyra | Dalfampridine | Acorda | Aurobindo Pharma |
| 1/23/2017 | Ampyra | Dalfampridine | Acorda | Actavis |
| 1/24/2017 | Ambien CR | Zolpidem Tartrate | Sanofi Aventis | Sun Pharma Global |
| 1/24/2017 | Dibenzyline | Phenoxybenzamine Hydrochloride | Concordia Pharms | Par Pharm |
| 1/26/2017 | Zithromax | Azithromycin | Pfizer | Mylan Labs |
| 1/26/2017 | Zanaflex | Tizanidine Hydrochloride | Acorda | Par Pharm |
| 1/27/2017 | Nimbex Preservative Free / Nimbex | Cisatracurium Besylate Preservative Free | Abbvie | Jiangsu Hengrui Med |
| 1/27/2017 | Namzaric | Memantine Hydrochloride / Donepezil Hydrochloride | Forest Labs | Amneal Pharms |
| 1/31/2017 | Eloxatin | Oxaliplatin | Sanofi Aventis / Teva | Fresnius Kabi USA |
| 1/31/2017 | Patanase | Olopatadine Hydrochloride | Novartis | Perrigo |
| 1/31/2017 | Xopenex | Levalbuterol Hydrochloride | Oak Pharms | Aurobindo Pharma |
| 1/31/2017 | Xenazine | Tetrabenazine | Valeant Pharms | Apicore US |
| 2/1/2017 | Triamicnolone Acetonide | Triamcinolone Acetonide | Mylan | Lupin |
| 2/2/2017 | Pravachol | Pravastatin Sodium | Bristol Myers Squibb | Aurobindo Pharma |
| 2/2/2017 | Inspra | Eplerenone | GD Searle | Mylan |
| 2/2/2017 | Plavix | Clopidogrel Bisulfate | Sanofi Aventis | CSPC OUYI Pharm |
| 2/2/2017 | Femcon FE | Nexesta Fe | Apil | Aurobindo Pharma |
| 2/3/2017 | Livalo | Pitavastatin Calcium | Kowa | Orient Pharma |
| 2/3/2017 | Livalo | Pitavastatin Calcium | Kowa | Sawai USA |
| 2/6/2017 | Heparin Sodium | Heparin Sodium | Fresenius Kabi USA / West-Ward Pharms | Gland Pharma |
| 2/6/2017 | Suprax | Cefixime | Lupin Ltd | Belcher Pharms |
| 2/7/2017 | Amidate | Etomidate | Hospira | Mylan |
| 2/8/2017 | Robaxin / Robaxin-750 | Methocarbamol | Auxilium Pharms | Atlas Pharms |
| 2/10/2017 | Activella | Estradiol / Norethindrone Acetate | Amneal Pharms | Mylan |
| 2/10/2017 | Eloxatin | Oxaliplatin | Sanofi Aventis / Teva | Gland Pharma |
| 2/10/2017 | Eloxatin | Oxaliplatin | Sanofi Aventis / Teva | Cipla |
| 2/13/2017 | Exelon | Rivastigmine Tartrate | Novartis | Cadila Pharms |
| 2/13/2017 | Fusilev | Levoleucovorin Calcium | Spectrum Pharms | Actavis |
| 2/13/2017 | Cyklokapron | Tranexamic Acid | Pharmacia and Upjohn | Gland Pharma |
| 2/13/2017 | Avelox | Moxifloxacin Hydrochloride | Bayer Healthcare | Novel Labs |
| 2/13/2017 | Fusilev | Levoleucovorin Calcium | Spectrum Pharms | Amneal Pharms |
| 2/13/2017 | Ella | Logilia | Lab HRA Pharma | Teva |
| 2/14/2017 | Reclast | Zoledronic Acid | Novartis | Mylan |
| 2/16/2107 | Clobex | Clobetasol Propionate | Galderma Labs | Zydus Pharms USA |
| 2/16/2017 | Diflucan | Fluconazole | Pfizer | Zydus Pharms USA |
| 2/17/2017 | Geodon | Ziprasidone Hydrochloride | Pfizer | MacLeods Pharms |
| 2/17/2017 | Toviaz | Fesoterodine Fumarate | Pfizer | Aurobindo Pharma |
| 2/17/2017 | Aciphex | Rabeprazole Sodium | Eisai | Aurobindo Pharma |
| 2/17/2017 | Bentyl / Bentyl Preservative Free | Dicyclomine Hydrochloride | Forest Labs | Luitpold Pharms |
| 2/22/2017 | Zyvox | Linezolid | Pharmacia and Upjohn | Zydus Pharms USA |
| 2/23/2017 | Glucophage XR | Metformin Hydrochloride | Bristol Myers Squibb | Intellipharmaceutics |
| 2/23/2017 | Suprep Bowel Prep Kit | Sodium Sulfate / Potassium Sulfate / Magnesium Sulfate | Braintree Labs | Novel Labs |
| 2/23/2017 | Sporanox | Itraconazole | Janssen | Jubilant Generics |
| 2/23/2017 | Edecrin | Ethacrynic Acid | Aton | West-Ward Pharms |
| 2/24/2017 | Amidate | Etomidate | Hospira | Aurobindo Pharma |
| 2/24/2017 | Tamiflu | Oseltamivir Phosphate | Roche | Nesher Pharms |
| 2/27/2017 | Temodar | Temozolomide | Merck Sharp Dohme | Accord Healthcare |
| 2/27/2017 | Dacogen | Decitabine | Otsuka Pharm | Accord Healthcare |
| 2/27/2017 | Zomig | Zolmitriptan | IPR | PLD Acquisitions |
| 2/28/2017 | Alkeran | Melphalan Hydrochloride | Apotex | Sagent Pharms |
| 2/28/2017 | Fludarabine Phosphate | Fludarabine Phosphate | Sandoz | Actavis |
| 2/28/2017 | Requip | Ropinirole Hydrochloride | GlaxoSmithKline | Accord Healthcare |
| 2/28/2017 | Cellcept | Mycophenolate Mofetil Hydrochloride | Roche Palo | Akorn |
| 2/28/2017 | Axiron | Testosterone | Eli Lilly | Perrigo |
| 2/28/2017 | Xeloda | Capecitabine | Hoffmann LA Roche | Amneal Pharms |
| 2/28/2017 | Viramune XR | Nevirapine | Boehringer Ingelheim | Aurobindo Pharma |
| 2/28/2017 | Prometrium | Progesterone | Virtus Pharms | Dr Reddys Labs |
| 2/28/2017 | Cyklokapron | Tranexamic Acid | Pharmacia and Upjohn | Amneal Pharms |
| 3/2/2017 | Zyvox | Linezolid | Pharmacia and Upjohn | Sagent Pharms |
| 3/3/2017 | Epivir | Lamivudine | VIIV Healthcare | Cipla |
| 3/3/2017 | Ritalin | Methylphenidate Hydrochloride | Novartis | Nostrum Labs |
| 3/3/2017 | Zanaflex | Tizanidine Hydrochloride | Acorda | Zydus Pharms USA |
| 3/6/2017 | Nexium IV | Esomeprazole Sodium | Astrazeneca | Deva Holding |
| 3/7/2017 | Maxalt-MLT | Rizatriptan Benzoate | Merck | Unichem Labs |
| 3/7/2017 | Maxalt | Rizatriptan Benzoate | Merck | Unichem Labs |
| 3/8/2017 | Nulytely / Nulytely-Flavored | Peg-3350 / Potassium Chloride / Sodium Bicarbonate / Sodium Chloride | Braintree | Breckenridge Pharms |
| 3/9/2017 | Zemplar | Paricalcitol | Abbvie | Amneal Pharms |
| 3/10/2017 | Aromasin | Exemestane | Pharmacia and Upjohn | Mylan |
| 3/10/2017 | Neurontin | Gabapentin | Pfizer | Teva |
| 3/14/2017 | Metrogel | Metronidazole | Galderma Labs | Taro Pharm |
| 3/14/2017 | Zanaflex | Tizanidine Hydrochloride | Acorda | Par Pharm |
| 3/17/2017 | Astelin | Azelastine Hydrochloride | Meda Pharms | Upsher-Smith Labs |
| 3/17/2017 | Zyflo CR | Zileuton | Chiesi USA | Pack Pharms |
| 3/17/2017 | Mucinex DM (OTC) | Guaifenesin / Dextromethorphan Hydrobromide (OTC) | Reckitt Benckiser | Aurobindo Pharma |
| 3/17/2017 | Zosyn | Piperacillin / Tazobactam | Wyeth | Wockhardt Bio |
| 3/21/2017 | Crestor | Rosuvastatin Calcium | IPR | Alkem Labs |
| 3/21/2017 | Eloxatin | Oxaliplatin | Sanofi Aventis / Teva | Accord Healthcare |
| 3/22/2017 | Zosyn | Piperacillin / Tazobactam | Wyeth | Wockhardt Bio |
| 3/22/2017 | Ultracet | Tramadol Hydrochloride / Acetaminophen | Janssen | Aurobindo Pharma |
| 3/22/2017 | Alkeran | Melphalan | Apotex | Alvogen Malta |
| 3/22/2017 | TOBI | Tobramycin | Novartis | Lupin |
| 3/23/2017 | Cymbalta | Duloxetine Hydrochloride | Eli Lilly | MacLeods Pharms |
| 3/24/2017 | Aricept | Donepezil Hydrochloride | Eisai | Zhejiang Hisun Pharm |
| 3/24/2017 | Venlafaxine Hydrochloride | Venlafaxine Hydrochloride | Osmotica Pharm | Nostrum Labs |
| 3/24/2017 | Busulflex | Busulfan | Otsuka Pharm | Pharmascience |
| 3/24/2017 | Neurontin | Gabapentin | Pfizer | Epic Pharma |
| 3/27/2017 | Lipitor | Atorvastatin Calcium | Pfizer | Teva |
| 3/27/2017 | Merrem | Meropenem | Astrazeneca | Aurobindo Pharma |
| 3/27/2017 | Desonide | Desonide | Perrigo | Hi-Tech Pharmacal |
| 3/28/2017 | Epzicom | Abacavir Sulfate / Lamivudine | ViiV Healthcare | Cipla |
| 3/28/2017 | Epzicom | Abacavir Sulfate / Lamivudine | ViiV Healthcare | Lupin |
| 3/29/2017 | Femcon FE | Noretindrone / Ethinyl Estradiol / Ferrous Fumarate | Apil | Accord Healthcare |
| 3/31/2017 | Rapaflo | Silodosin | Allergan | Sandoz |
GENERICally Speaking Spring 2017
Related Publications
Second Quarter
GENERICally Speaking: A Hatch-Waxman Litigation Bulletin
Oren Langer, Christopher Pinahs, Emily Tremblay, and Christine May
June 25, 2024
Amarin Pharma, Inc. v. Hikma Pharms. USA Inc.
GENERICally Speaking Hatch Waxman Bulletin
June 10, 2024
Teva Branded Pharm. Products R&D, Inc. v. Amneal Pharms. of NY, LLC
GENERICally Speaking Hatch Waxman Bulletin
April 30, 2024
Pharmacyclics LLC v. Alvogen Pine Brook LLC
GENERICally Speaking Hatch Waxman Bulletin
First Quarter
GENERICally Speaking: A Hatch-Waxman Litigation Bulletin
Oren Langer, Christopher Pinahs, Emily Tremblay, and Christine May
Related News
October 14, 2022
September 9, 2022
Back to Top
Any information that you send us in an e-mail message should not be confidential or otherwise privileged information. Sending us an e-mail message will not make you a client of Robins Kaplan LLP. We do not accept representation until we have had an opportunity to evaluate your matter, including but not limited to an ethical evaluation of whether we are in a conflict position to represent you. Accordingly, the information you provide to us in an e-mail should not be information for which you would have an expectation of confidentiality.
If you are interested in having us represent you, you should call us so we can determine whether the matter is one for which we are willing or able to accept professional responsibility. We will not make this determination by e-mail communication. The telephone numbers and addresses for our offices are listed on this page. We reserve the right to decline any representation. We may be required to decline representation if it would create a conflict of interest with our other clients.
By accepting these terms, you are confirming that you have read and understood this important notice.
If you are interested in having us represent you, you should call us so we can determine whether the matter is one for which we are willing or able to accept professional responsibility. We will not make this determination by e-mail communication. The telephone numbers and addresses for our offices are listed on this page. We reserve the right to decline any representation. We may be required to decline representation if it would create a conflict of interest with our other clients.
By accepting these terms, you are confirming that you have read and understood this important notice.